Developed at pharma grade Wadenswil, Switzerland facility, the EFLA HyperPure technology, which the company claims to be safe and effective, utilizes cross flow membrane microfiltration process to separate unwanted lipophilic compounds and extract stable and pure botanicals.
Processing of botanical materials removes undesirable contaminants, maintain the integrity of the plant’s inherent multi-component system and medicinal compounds, and protect the environment during the process, according to the company.
Frutarom vice president health business Jeffrey Lind was quoted by Ingredients Network as saying that the increase in the production capacity will allow the company to respond quickly to customers’ demands.
"The majority of Frutarom’s core products are produced using this technology, including: Benolea (olive leaf), Portusana (purslane) and Neuravena (avena/green oat), resulting in ingredients with superior safety and stability," Lind added.
"The addition of proprietary clinical studies behind these products ensures the best combination of high quality, safety and effective natural ingredients."